Target Audience:
This activity has been designed to meet the educational needs of gastroenterologists and other healthcare providers involved in the care of patients with congenital sucrase-isomaltase deficiency (CSID) and irritable bowel syndrome (IBS).
Learning Objectives
After completing this activity, the participant should be better able to:
- Describe the prevalence of CSID in patients with common GI disorders.
- Incorporate current diagnostic strategies to differentiate CSID from other causes of persistent diarrhea seen in clinical practice, particularly among patients with suspected IBS.
- Summarize the benefits and limitations of current treatment strategies for CSID.
Accreditation Statement
 |
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and the Gi Health Foundation. Medical Education Resources is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation
Medical Education Resources designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Relevant Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
Disclosures:
Tanaz Farzan Danialifar, MD: Consulting Fees: QOL Medical
Julianne Messick, PharmD: No relevant financial relationships to disclose.
Method of Participation
There are no fees for participating in and receiving credit for this activity. During the period December 11, 2023 through December 11, 2024, participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest by recording the best answer to each question, and 4) complete the evaluation form. A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 75% or better. Please visit http://bit.ly/csid-proceedings-pediatric to complete the posttest and evaluation.
Media
Internet/Digital
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, the Gi Health Foundation, and/or QOL Medical LLC. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Fee Information
There is no fee for this educational activity.
This activity is jointly provided by MER and the Gi Health Foundation.
This program is supported by an educational grant from QOL Medical LLC.